TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

New US hypertension guidelines, the first since 2017, released today reinforce prior recommendations that prioritize lowering ...

The study can’t supplant an RCT in this space, but does provide clear support for both short DAPT and P2Y12 inhibitors ...

Continuing the conversation, Juan Granada hears about Guido Ascione’s recent presentation on the global burden of ...

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

The advantage over balloon angioplasty in this higher-risk subset was consistent with the results seen in single-layer ISR.

The findings are encouraging but likely don’t apply to countries with ready access to thrombectomy, one expert says.

Effects are more modest in placebo-controlled versus nonrandomized studies, with experts calling for further research.

Johanne Silvain, Gilles Montalescot, and C. Michael Gibson discuss the effects of beta-blocker interruption in post-MI ...

Despite the rising interest in procedures like TEER and LAAO, finances may sway decision-making, experts caution.

While increasing accessibility is “laudable,” it can come at a cost when patients leave the VA for procedures, Jay Giri says.

Access to rehabilitation is a “lifeline” for patients that needs to be protected and preserved to ensure their recovery.